Literature DB >> 12623362

Carcinoma of the gallbladder.

Sanjeev Misra1, Arun Chaturvedi, Naresh C Misra, Indra D Sharma.   

Abstract

Carcinoma of the gallbladder is the most common malignant tumour of the biliary tract and a particularly high incidence is observed in Chile, Japan, and northern India. The aetiology of this tumour is complex, but there is a strong association with gallstones. Owing to its non-specific symptoms, gallbladder carcinoma is generally diagnosed late in the disease course, but if a patient with gallstones experiences a sudden change of symptoms, then a cancer diagnosis should be considered. Treatment with radical or extended cholecystectomy is potentially curative, although these procedures are only possible in 10-30% of patients. There is no role for cytoreductive surgery in this disease. If a gallbladder carcinoma is discovered via pathological examination of tissue samples, then the patient should be examined further and should have radical surgery if the tumour is found to be T1b or beyond. Additional port-site excision is necessary if the patient has already had their gallbladder removed during laparoscopy; however, patients with an intact gallbladder who are suspected to have gallbladder carcinoma should not undergo laparoscopic cholecystectomy. Patients with advanced inoperable disease should receive palliative treatment; however, the role of chemotherapy and radiation in these patients needs further evaluation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12623362     DOI: 10.1016/s1470-2045(03)01021-0

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN: 1470-2045            Impact factor:   41.316


  232 in total

1.  Postoperative chemoradiotherapy for gallbladder cancer.

Authors:  K Kim; E K Chie; J-Y Jang; S W Kim; S-W Han; D-Y Oh; S-A Im; T-Y Kim; Y-J Bang; S W Ha
Journal:  Strahlenther Onkol       Date:  2012-03-10       Impact factor: 3.621

2.  Immunohistochemical evidence of the prognostic value of hedgehog pathway components in primary gallbladder carcinoma.

Authors:  Jinmao Li; Tao Wu; Jianguo Lu; Yizhan Cao; Nuan Song; Tao Yang; Rui Dong; Yuan Yang; Li Zang; Xilin Du; Shengzhi Wang
Journal:  Surg Today       Date:  2012-03-10       Impact factor: 2.549

3.  The impact of routine histopathological examination on cholecystectomy specimens from an Asian demographic.

Authors:  K F Chin; A A Mohammad; Y Y Khoo; T Krishnasamy
Journal:  Ann R Coll Surg Engl       Date:  2012-04       Impact factor: 1.891

4.  Gallbladder cancer: the basics.

Authors:  Eldon A Shaffer
Journal:  Gastroenterol Hepatol (N Y)       Date:  2008-10

5.  Successful diagnosis of gallbladder carcinoma coexisting with adenomyomatosis by 18F-FDG-PET--report of a case.

Authors:  Keiichi Suzuki; Susumu Watada; Mitsui Yoko; Tadaki Nakahara; Yusuke Kumamoto
Journal:  J Gastrointest Cancer       Date:  2011-12

6.  Extent of resection for T2N0 gallbladder carcinoma regarding concurrent extrahepatic bile duct resection.

Authors:  Sung-Chan Gwark; Shin Hwang; Ki-Hun Kim; Yong-Joo Lee; Kwang-Min Park; Chul-Soo Ahn; Deok-Bog Moon; Tae-Yong Ha; Gi-Won Song; Dong-Hwan Jung; Gil-Chun Park; Sung-Gyu Lee
Journal:  Korean J Hepatobiliary Pancreat Surg       Date:  2012-11-30

7.  Surgical outcomes and prognostic factors influencing long-term survival in patients with gallbladder cancer.

Authors:  Sung Ha Lee; Jae Do Yang; Hong Pil Hwang; Hee Chul Yu; Baik Hwan Cho
Journal:  Korean J Hepatobiliary Pancreat Surg       Date:  2012-05-31

Review 8.  Surgical management of gallbladder carcinoma: a review.

Authors:  Kristin L Mekeel; Alan W Hemming
Journal:  J Gastrointest Surg       Date:  2007-09       Impact factor: 3.452

9.  Potential biomarkers for sensitivity of gallbladder cancer cells to gemcitabine.

Authors:  Chao Yang; Ming Xu; Huo-Jian Shen; Hong-Yi Zhu; Fu Li; Min He; Tao Chen; Jian Wang; Wei-Jin Shi; Fu Ji
Journal:  Int J Clin Exp Pathol       Date:  2014-01-15

10.  Association of adrenergic receptor gene polymorphisms in gallbladder cancer susceptibility in a North Indian population.

Authors:  Rajani Rai; Kiran L Sharma; Sanjeev Misra; Ashok Kumar; Balraj Mittal
Journal:  J Cancer Res Clin Oncol       Date:  2014-02-21       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.